sacituzumab
gilead sciences
['breast', 'trodelvy', 'gilead']
it s been weeks since gilead touted clinically meaningful overall survival results from a second interim analysis of trodelvy in a subset of metastatic breast cancer patients. now we finally have a look at the hard data at #esmo22. 
The biopharma world is here. Get the industry’s most comprehensive daily news report at https://t.co/rXFyNyZcJs